Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Scrip’s Top Five Stories Of 2018

Jan 04 2019

• By Alex Shimmings

2019 2018 Perspectives

Related Content

Japan Price Reforms - Major Takeaways

Apr 11 2018

Momenta Is Exiting Biosimilars; Is That A Bellwether For Biosimilar Sentiment?

Oct 02 2018

Merck Steps Out Of Insulin Glargine Market, But Says It Remains Committed To Biosimilars

Oct 11 2018

Who's Promised What: A Guide To Pharma Drug Pricing Pledges

Jul 23 2018

Pfizer Consumer Combo Deal Frees Capital For GSK Pharma Investment

Dec 19 2018

AbbVie Defends Humira With Aggressive Discount In First EU Tender

Nov 01 2018

Takeda, Shire Finally Seal £46bn Deal

May 08 2018

‘Drastic’ Japan Price Reforms Hitting R&D Incentives, Plans - EFPIA

Nov 09 2018

Novartis Gives Up On Rituxan Biosimilar For US Market

Nov 05 2018

FDA's Gottlieb: 'Pricing And Reimbursement Mischief' Holding Back Biosimilar Market

Mar 08 2018

Deal Watch: Amazon Moves Into Rx Services With Acquisition Of PillPack

Jul 02 2018

Pfizer Agrees To Roll Back Prices On 40 Drugs, Yielding To Pressure From Trump

Jul 11 2018

Related Companies

Takeda Pharmaceutical Co. Ltd.

Takeda Pharmaceutical Co. Ltd.

GSK plc

Novartis AG

Sanofi

Sanofi

Pfizer Inc.

AbbVie Inc.

Allergan plc

Les Laboratoires Servier

Celltrion, Inc.

Johnson & Johnson

Viatris Inc.

Amgen, Inc.

Merck & Co., Inc.

Momenta Pharmaceuticals, Inc.

Roche Holding AG

Alcon Inc.

Aurobindo Pharma Limited

Endocyte, Inc.

Advanced Accelerator Applications SA

AveXis, Inc.

AstraZeneca PLC

MedPlus Inc.

Tesaro, Inc.

Additional Topics

Companies Commercial Pricing Strategies Pricing Debate BioPharmaceutical

More from Business

More from Scrip

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window